Navigation Links
BRCA Mutations Don't Spot All High-Risk Women
Date:5/5/2008

Family history and atypical cells also indicate high risk of second cancer, study finds,,

MONDAY, May 5 (HealthDay News) -- In women who have been diagnosed with breast cancer, having a known mutation in the BRCA 1 or 2 genes raises the risk of a second cancer, and many of these women choose to have their second breast removed before that has a chance to happen.

However, new research suggests that women who don't have these genetic mutations may still face an increased risk of a second cancer, especially if they have a family history of breast cancer or atypical breast cells.

The study involved women with a family history of breast cancer, although only some had a BRCA mutation. The researchers found that the risk of cancer in the second breast was about 10 percent, regardless of whether the woman carried a BRCA mutation or not.

The findings were slated to be presented Sunday at the American Society of Breast Surgeons' annual meeting, in New York City.

The study suggests that "we may not have identified all of the genes associated with breast cancer," according to study author Dr. Shawna Willey, director of the Betty Lou Ourisman Breast Health Center at the Lombardi Cancer Center at Georgetown University in Washington D.C.

Many high-risk women may not be advised to have a prophylactic mastectomy even though it could be potentially lifesaving, she added.

"Having a prophylactic mastectomy should not be a knee-jerk reaction to a diagnosis of breast cancer. Women need to consider this data, as well as other data, and decide whether or not this is a measure they want to take," advised Willey. She said the findings may also add to the debate about which breast cancer patients should have sentinel lymph node biopsies.

"Prevention of secondary breast cancer is becoming increasingly important," said Dr. Julia Smith, director of the Lynne Cohen Breast Cancer Preventative Car
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Second breast cancer may be greater than thought for high-risk women without BRCA mutations
2. Different mutations in single gene suggest Parkinsons is primarily an inherited genetic disorder
3. Gene Mutations for Rare Heart Disease Also Found in Kids
4. Einstein researchers discover gene mutations linked to longer lifespans
5. 2 Mutations Were Critical to Spread of 1918 Flu
6. Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations
7. Scientists explore factors contributing to DNA mutations
8. Genetic Mutations Boost Prostate Cancer Risk
9. BRCA Mutations Dont Raise Breast Cancer Risk Equally
10. Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
11. Gene Mutations May Cause Rare Neonatal Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
BRCA Mutations Don't Spot All High-Risk Women
BRCA Mutations Don't Spot All High-Risk Women
Other Medicine News:Health News:Kim Kardashian Says Real Women Keep Their Curves With 'Fit In Your Jeans By Friday' 2Health News:Endo to Present at Bank of America and Merrill Lynch 2009 Health Care Conference 2Health News:Endo to Present at Bank of America and Merrill Lynch 2009 Health Care Conference 3Health News:Endo to Present at Bank of America and Merrill Lynch 2009 Health Care Conference 4Health News:New Jersey IT Services Firm to Host Educational Luncheon Event, EMR & Information Technology for the Specialty Medical Practice 2Health News:New Jersey IT Services Firm to Host Educational Luncheon Event, EMR & Information Technology for the Specialty Medical Practice 3Health News:Practicing Clinicians Exchange Forms Partnership With Restless Legs Syndrome Foundation 2Health News:Practicing Clinicians Exchange Forms Partnership With Restless Legs Syndrome Foundation 3Health News:Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference 2Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 2Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 3Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 4Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 5Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 6Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 7Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 8Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 9Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 10Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 11
Breaking Medicine Technology:Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Policy transparency key to saving worlds fisheries 8955 1Policy transparency key to saving worlds fisheries 8955 2Policy transparency key to saving worlds fisheries 8955 3Policy transparency key to saving worlds fisheries 8955 4Policy transparency key to saving worlds fisheries 8955 5Domestic Violence Expert Comments on Chris Brown Plea Deal 49697 1Domestic Violence Expert Comments on Chris Brown Plea Deal 49697 2Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 1Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 2Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 3